Vitrectomy for Epiretinal Membrane: Does the Association with an Inflammatory Ocular Pathology Affect Outcomes?

Authors

  • Joana Santos-Oliveira Department of Ophthalmology, Centro Hospitalar e Universitário São João, Porto, Portugal https://orcid.org/0000-0003-0260-8469
  • Sónia Torres-Costa Department of Ophthalmology, Centro Hospitalar e Universitário São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal https://orcid.org/0000-0002-7079-9554
  • Manuel Falcão Department of Ophthalmology, Centro Hospitalar e Universitário São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal https://orcid.org/0000-0003-4718-0910
  • Luís Figueira Department of Ophthalmology, Centro Hospitalar e Universitário São João, Porto, Portugal; Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal https://orcid.org/0000-0002-4481-882X
  • Amândio Rocha-Sousa Department of Ophthalmology, Centro Hospitalar e Universitário São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal https://orcid.org/0000-0001-8374-0298

DOI:

https://doi.org/10.48560/rspo.38372

Keywords:

Epiretinal Membrane, Vitrectomy, Macular Edema, Uveitis, Visual Acuity

Abstract

INTRODUCTION: Epiretinal membrane (ERM) is a common complication in eyes with inflammatory ocular pathologies. This study aims to compare anatomical and functional outcomes following vitrectomy in patients with ERM, either idiopathic or secondary to an inflammatory ocular condition.

METHODS: This retrospective study was conducted in Centro Hospitalar Universitario de Sao Joao, Porto, Portugal. Medical records from the Immunopathology and Surgical Retina consultations (2013-2023) were reviewed. Two cohorts were established: Group A (idiopathic ERM) and Group B (ERM secondary to an inflammatory ocular pathology). Data collected included: demographic information, pre- and post- surgery best- corrected visual acuity (BCVA), surgical complications, intraocular pressure variation, and macular optical coherence tomography metrics.

RESULTS: Forty- two eyes from 42 patients were included, 21 in each group. No significant differences were observed between groups concerning the sex (p = 0.355) or laterality of the affected eye (p = 0.212). However, mean patient age at surgery was significantly lower in group B (p< 0.001). The change in BCVA from pre- surgery to 6 months and 1 year post- surgery was not significantly different between the two groups (p = 0.493 and p = 0.219, respectively). Preoperative macular edema was significantly more frequent in Group B (p< 0.001), while Group A exhibited a higher mean central macular thickness (CMT) (p = 0.030). In Group A, the CMT decreased from 492.24±81.98μm pre- surgery to 415.71±43.12μm at 6 months and 407.71±42.66μm at 1- year post- surgery. Similarly, in Group B, the CMT reduced from 471.00±146.05μm pre- surgery to 351.38±102.06μm at 6 months and 345.63±104.88μm at 1- year post- surgery. No significant differences were observed between the CMT at 6 months and 1 year in either group. The rates of surgical complications and the presence of ocular hypertension after surgery were comparable between the groups (p = 0.707 and p = 0.120, respectively).

CONCLUSION: BCVA and CMT improvements following vitrectomy were comparable between patients with idiopathic ERM and those with ERM secondary to inflammatory ocular pathology, with a similar safety profile observed in both groups.

Downloads

Download data is not yet available.

References

Kalogeropoulos D, Lotery AJ, Gupta B, Lash S, Antonakis S. Epiretinal membranes in patients with uveitis: an update on the current state of management. Int Ophthalmol. 2024 Jun 28;44(1):291. doi: 10.1007/s10792-024-03199-2.

Fung AT, Galvin J, Tran T. Epiretinal membrane: A review. Clin Exp Ophthalmol. 2021;49:289-308. doi: 10.1111/ceo.13914.

Multicenter Uveitis Steroid Treatment Trial Research Group; Kempen JH, Altawel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149:550-561.e10. doi: 10.1016/j.ajo.2009.11.019.

Nicholson BP, Zhou M, Rostamizadeh M, Mehta P, Agrón E, Wong W, et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121:2393-8. doi: 10.1016/j.ophtha.2014.06.015.

Grajewski RS, Boelke AC, Adler W, Meyer S, Caramoy A, Kirchhof B, et al. Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. Eye. 2016;30:1415-23. doi: 10.1038/eye.2016.133.

Guemes-Villahoz N, Diaz-Valle D, Fonollosa A, Jimenez-Santos M, Narvaez-Palazon C, Adan A. Spontaneous resolution

Iannetti L, Accorinti M, Liverani M, Caggiano C, Abdulaziz R, Pivetti-Pezzi P. Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. Ocul Immunol Inflamm. 2008;16:155-60. doi: 10.1080/09273940802187466.

Holladay JT. Proper Method for Calculating Average Visual Acuity. J Refract Surg. 1997;388-91. doi: 10.3928/1081-597X-19970701-16.

Mori K, Gehlbach PL, Sano A, Deguchi T, Yoneya S. Comparison of epiretinal membranes of differing pathogenesis using optical coherence tomography. Retina. 2004;24:57-62. doi: 10.1097/00006982-200402000-00009.

Yazici AT, Alagoz N, Celik HU, Bozkurt E, Alagoz C, Cakir M, et al. Idiopathic and secondary epiretinal membranes: do they differ in terms of morphology? An optical coherence tomography-based study. Retina. 2011;31:779-84. doi: 10.1097/IAE.0b013e3181ef8786.

Yap A, Lu LM, Sims JL, Welch S, Niederer RL. Epiretinal membrane in uveitis: Rate, visual prognosis, complications and surgical outcomes. Clin Exp Ophthalmol. 2024;52:54-62. doi: 10.1111/ceo.14338

Cristescu IE, Ivanova T, Moussa G, Ferrara M, Patton N, Dhawahir-Scala F, et al. Functional and Anatomical Outcomes of Pars Plana Vitrectomy for Epiretinal Membrane in Patients with Uveitis. Diagnostics. 2022;12:3044. doi: 10.3390/diagnostics12123044.

Rao P, Todorich B, Yonekawa Y, Wang J, Sobrin L, Faia LJ. Surgical outcomes of epiretinal membranes in patients with a history of well- controlled preoperative uveitis. Ophthalmol Retina. 2018;2:192-6. doi: 10.1016/j.oret.2017.07.002.

Kim J, Rhee KM, Woo SJ, Yu YS, Chung H, Park KH. Longterm temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am J Ophthalmol. 2010;150:701-9. e1. doi: 10.1016/j.ajo.2010.05.037.

Abu- Ain M, Shtanawi R, Shehadeh I, Khan MI. Long- term visual acuity and optical coherence tomography changes after vitrectomy for idiopathic epiretinal membranes. Clin Ophthalmol. 2023;17:693-700. doi: 10.2147/OPTH.S401017.

Coassin M, Mori T, Mastrofilippo V, Sborgia G, De Maria M, Carla MM, et al. Surgical management of post- uveitic epiretinal membranes. Eur J Ophthalmol. 2021;11206721211017750. doi: 10.1177/11206721211017750.

Downloads

Published

2026-03-19

How to Cite

Santos-Oliveira, J., Torres-Costa, S., Falcão, M., Figueira, L., & Rocha-Sousa, A. (2026). Vitrectomy for Epiretinal Membrane: Does the Association with an Inflammatory Ocular Pathology Affect Outcomes?. Revista Sociedade Portuguesa De Oftalmologia, 50(1), 52–58. https://doi.org/10.48560/rspo.38372

Issue

Section

Original Article